No abstract available
Keywords:
artificial intelligence; data science; high-throughput; omics; rare disease.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. SB was supported by the French government, through the UCA JEDI Investments in the Future project managed by the National Research Agency (ANR) under reference number ANR-15-IDEX-01, LF by Junta de Andalucía through grant UMA20-FEDERJA-045 (includes FEDER funds) and FES by the Academy of Finland and the National Institute of Health (NIH, USA) grant number 352266.